Ligand validation:6JLK

LMG: 1,2-DISTEAROYL-MONOGALACTOSYL-DIGLYCERIDE

LMG is a Ligand Of Interest in 6JLK designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6JLK_LMG_B_622	83%	48%	0.073	0.942	0.92	1.07	2	5	1	0	93%	1
6JLK_LMG_b_629	79%	49%	0.081	0.938	0.9	1.07	2	5	3	0	93%	1
6JLK_LMG_d_413	78%	52%	0.082	0.937	0.92	0.94	2	3	2	0	93%	1
6JLK_LMG_D_413	75%	52%	0.093	0.938	0.87	1	2	5	2	0	93%	1
6JLK_LMG_c_501	64%	46%	0.096	0.908	0.89	1.17	2	4	3	0	93%	1
6JLK_LMG_A_421	64%	47%	0.094	0.905	0.93	1.1	2	4	5	0	93%	1
6JLK_LMG_c_523	62%	48%	0.098	0.901	0.9	1.12	2	4	3	0	93%	1
6JLK_LMG_C_519	59%	50%	0.103	0.897	0.95	0.99	2	4	6	0	93%	1
6JLK_LMG_c_524	45%	43%	0.113	0.854	0.96	1.24	2	7	3	0	93%	1
6JLK_LMG_C_520	36%	46%	0.12	0.824	0.95	1.12	2	4	4	0	93%	1
6JLK_LMG_z_101	31%	44%	0.132	0.85	1.08	1.1	2	3	6	0	71%	1
6JLK_LMG_Z_101	29%	39%	0.135	0.853	0.96	1.39	2	6	2	0	67%	1
5GTI_LMG_m_101	91%	46%	0.054	0.954	0.89	1.17	2	6	0	0	93%	1
5V2C_LMG_B_621	91%	30%	0.074	0.972	1.09	1.67	4	8	0	0	93%	1
6JLP_LMG_M_101	85%	48%	0.069	0.946	0.92	1.08	2	4	3	0	93%	1
6JLL_LMG_B_622	84%	48%	0.068	0.943	0.93	1.08	2	4	1	0	93%	1
5WS6_LMG_j_101	84%	48%	0.077	0.952	0.88	1.14	2	5	0	0	93%	1
7M78_LMG_B_849	99%	46%	0.056	0.986	0.71	1.37	1	8	1	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.